Together with the report that PLK1 is overexpressed in colorectal cancers, the majority of which are characterized by dysregulated Wnt signalling [27], it is of interest to test whether PLK1 plays a role in regulating Wnt/β-catenin signalling in the future. The gene discussed is PLK1; the disease is colorectal cancer.